101～200

101. Periklis A. Davlouros, Philip J, et al. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic

resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll

Cardiol2002; 40: 2044-2052.

102. Piran S, Veldtman G, Siu S, et al. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation 2002; 105:

1189-1194.

103. Salehian O, Schwerzmann M, Merchant N, et al. Assessment of systemic right ventricular function in patients with transposition of the great arteries

using the myocardial performance index: comparison with cardiac magnetic resonance imaging. Circulation 2004; 110: 3229-3233.

104. Graham TP Jr, Bernard YD, Mellen BG, et al. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional

study. J Am Coll Cardiol 2000; 36: 255-261.

105. Lange R, Hörer J, Kostolny M, et al. Presence of a ventricular septal defect and the Mustard operation are risk factors for late mortality after the atrial

switch operation: thirty years of follow-up in 417 patients at a single center. Circulation 2006; 114: 1905-1913.

106. Hörer J, Schreiber C, Cleuziou J, et al. Improvement in long-term survival after hospital discharge but not in freedom from reoperation after the change

from atrial to arterial switch for transposition of the great arteries. J Thorac Cardiovasc Surg 2009; 137: 347-354.

107. Veldtman GR, Nishimoto A, Siu S, et al. The Fontan procure in adults. Heart 2001; 86: 330-335.

108. Diller GP, Giardini A, Dimopoulos K, et al. Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study

including cardiopulmonary exercise testing in 321 patients. Eur Heart J 2010; 31: 3073-3083.

109. 坂崎尚徳，丹羽公一郎，中澤誠，赤木禎治．本邦におけるEisenmenger症候群成人例の臨床像の検討．日本小児循環器学会雑誌 2010；26：168-175.

110. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007; 115: 1039-1050.

111. Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998; 19: 1845-1855.

112. Cantor WJ, Harrison DA, Moussadji JS, et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol 1999;

84: 677-681.

113. Broberg CS, Bax BE, Okonko DO, et al. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with

cyanotic congenital heart disease. J Am Coll Cardiol 2006; 48: 356-365.

114. Trojnarska O, Gwizdala A, Katarzynski S, et al. The BNP concentrations and exercise capacity assessment with cardiopulmonary stress test in

cyanotic adult patients with congenital heart diseases. Int J Cardiol 2010; 139: 241-247.

115. Niwa K, Nakazawa M, Miyatake K, et al. Survey of prophylaxis and management of infective endocarditis in patients with congenital heart disease-

Japanese nationwide survey- Circ J 2003; 67: 585-591.

116. Nakatani S, Mitsutake K, Hozumi T, et al. Current characteristics of infective endocarditis in Japan-An analysis of 848 cases in 2000 and 2001. Circ J

2003; 67: 901-905.

117. Niwa K, Nakazawa M, Tateno S, et al. Infective endocarditis in congenital heart disease: Japanese national collaboration study. Heart 2005; 91: 795-

800.

118. Li W, Sommerville J. Infective endocarditis in the grownup congenital heart (GUCH) population. Eur Heart J 1998; 19: 166-173.

119. Day MD, Gauvreau K, Shulman S, et al. Characteristics of children hospitalized with infective endocarditis. Circulation 2009; 119: 865-870.

120. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis. Guidelines from the American Heart Association. Circulation 2007; 116:

1736-1754.

121. Ishiwada N, Niwa K, Tateno S, et al. Causative organism influences clinical profile and outcome of infective endocarditis in pediatric patients and adults

with congenital heart disease. Circ J 2005; 69: 1266-1270.

122. Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis andmanagement of infective endocarditis and its complication. Circulation 1998; 98: 2936-2948.

123. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings.

Am J Med 1994; 96: 200-209.

124. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-

638.

125. Ferrieri P, Gewitz MH, Gerber MA, et al. Unique features of infective endocarditis in childhood. Circulation 2002; 105: 2115-2127.

126. Sanfilippo AJ , Picard MH, Newell JB, et al Echocardiographic assessment of patients with infective endocarditis: prediction of risk for complications.

Am Coll Cardiol 1991; 18: 1191-1199.

127. Birmingham GD, Rhako PS, Ballantyne F III. Improved detection of infective endocarditis with transesophageal echocardiography. Am Heat J 1992;

123: 774-781.

128. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci,

and HACEK microorganisms. JAMA 1995; 274: 1706-1713.

129. Nomura F, Penny DJ, Menahem S. Surgical intervention for infective endocarditis in infancy and childhood. Ann Thorac Surg 1995; 60: 90-95.

130. Reinhartz O, Herrmann M, Redling F, et al. Timing of surgery in patients with acute infective endocarditis. J Cardiovasc Surg 1996; 37: 397-400.

131. Yoshinaga M, Niwa K, Niwa A, et al. Risk factors for inhospital mortality during infective endocarditis in patients with congenital heart disease.

Am J Cardiol 2008; 101: 114-118.

132. Thuny F, Di Salvo G, Belliard O, et al. Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography: A Prospective

Multicenter Study. Circulation 2005; 112: 69-75.

133. Moons P, De Volder E, Budts W, et al. What do adult patients and prevention of complications? A call for structured patient education. Heart 2001;

86:

74-80.

134. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis. Eur Heart J 2004; 25: 1-37, 267-

276.

135. Sakazaki H, Niwa K, Echigo S, et al. Predictive factors for long-term prognosis in adults with cyanotic congenital heart disease--Japanese multi-center

study. Int J Cardiol 2007; 120: 72-78.

136. Perloff JK, Koos B. Cyanotic congenital heart disease: a multisystem disorder. Congenital Heart Disease in Adults, 2nd edition (Perloff JK, Child JS

eds). WB Saunders 1998: 199-227.

137. Rosove MH, Perloff JK, Hocking WG, et al. Chronic hypoxemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet 1986;

2: 313-315.

138. 丹羽公一郎．チアノーゼ型先天性心疾患にみられる全身多臓器異常．新目で見る循環器病シリーズ14　成人先天性心疾患（丹羽公一郎，中澤誠編著）．メジカ

ルビュー社 2005：40-48.

139. Ootani Y, Yamaguchi M, Yoshimura N, et al. Vascular endothelial growth factor in children with congenital heart disease. Ann Thorac Surg 2003; 75:

1523-1526.

140. Silversides CK, Granton JT, Konen E, et al. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 2003; 42: 1982-1987.

141. Niwa K, Perloff JK, Kaplan S, et al. Eisenmenger syndrome in adults. ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll

Cardiol 1999; 34: 223-232.

142. Perloff JK, Hart EM, Greaves SM, et al. Proximal pulmonary arterial and intrapulmonary radiographic features of Eisenmenger syndrome and pr imary

pulmonary hypertension. Am J Cardiol 2003; 92: 182-187.

143. Perloff JK, Lotta H, Barsotti P, et al. Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease. Am J Cardiol 2000; 86: 1198-

1204.

144. 長嶋正實，丹羽公一郎，赤木禎治，他．チアノーゼ型先天性心疾患にみられる腎疾患の頻度，成因解析と診断，治療法の策定．日小循誌 2006；22：130-133.

145. Broberg C, Ujita M, Babu-Narayan S, et al. Massive pulmonary artery thrombosis with haemoptysis in adults with Eisenmenger syndrome. Heart 2004;

90: e63.

146. Burlet A, Drukker A, Guignard JP, et al. Renal function in cyanotic congenital heart disease. Nephron 1998; 81: 296-300.

147. Fujimoto Y, Matsushima M, Tsuzuki K, et al. Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an

angiotensin-converting enzyme inhibitor. Clin Nephrol 2002; 58: 95-102.

148. Ammash N, Warnes C. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol 1996; 28: 768-772.

149. Horigome H, Hiramatsu Y, Shigeta O, et al. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycethemia: J Am

Coll Cardiol 2002; 39: 1072-1077.

150. 堀米仁志，村上　卓，高橋実穂，他．成人チアノーゼ型心疾患における血液凝固系と頭部 MRI 所見．日小循誌2003；19：161.

151. Chugh R, Perloff JK, Fishbein M, et al. Extramural coronary arteries in adults with cyanotic congenital heart disease. Am J Cardiol 2004; 94: 1355-

1357.

152. Dickinson CJ. The aetiology of clubbing and hypertrophic osteoarthropathy. Eur J Clin Invest 1993; 23: 330-338.

153. Harinck E, Hutter PA, Hoorntje TM, et al. Air travel and adults with cyanotic congenital heart disease. Circulation 1996; 93: 272-276.

154. Scurr JH, Machin SJ, Bailey-King S, et al. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial.

Lancet 2001; 357: 1485-1489.

155. Pulmonary Embolism Prevention (PEP) trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin:

Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355: 1295-1302.

156. Bromberg CS, Uebing A, Cuomo L, et al. Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. Heart 2007; 93:

1599-1603.

157. Galie N, Hoeper MH, Humbert M, et al. Guideline for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2009; 30: 2493-2537.

158. Archer S, Weir EK, Wilkins MR, et al. Basic Science of pulmonary arterial hypertension for clinicians. Circulation 2010; 121: 2045-2066.

159. Beghetti M, Galie N. Eisenmenger syndrome. J Am Coll Cardiol 2009; 53: 733-740.

160. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease. Circulation 1958; 18: 533-547.

161. 八巻重雄．臨床家のための肺血管病変肺生検診断．メジカルレビュー社 2001.

162. Rabinovitch M, Haworth S, Castaneda A, et al. Lung Biopsy in congenital heart disease. A morphometric approach to pulmonary vascular disease.

Circulation 1978; 58: 1107-1122.

163. Oechslin E. Eisenmenger’s syndrome. Diagnosis and Management of Adult Congenital lHeart Disease Gatzoulis MA, Webb GD, Daubeney PEF. ed.

Elsevier Saunders, Philaderphia 2011: 358-370.

164. Perloff JK. Survival patterns without cardiac surgery or interventional cathetelization: a narrowing base. Perloff JK, Child JS ed. Congenital Heart

Disease in Adults. 3rd ed. WB Saunders, 2009: 25-67.

165. Gersony WM, Hayes CJ, Driscoll DJ, et al. Second natural history study of congenital heart defects. Quality of life of patients with aortic stenosis,

pulmonary stenosis, or ventricular septal defect. Circulation 1993; 87 (Suppl II): I52-165.

166. Saha A, Balkrishnan KG, Jaiswal PK, et al. Prognosis for patients with Eisenmenger ssyndrome of various aetiology. Int J Cardiol 1994; 45: 199-207.

167. Perloff JK. Adults with surgically treated congenital heart disease: sequelae and residua. JAMA 1983; 250: 2033-2036.

168. Perloff JK, Roberts NK, Cabeen WR. Left axis deviation: a reassessment. Circulation 1979; 60: 12-21.

169. Niwa K, Perloff JK, Bhuta SM, et al. Structural abnormalities of great arterial walls in congenital heart disease. Light and electron microscopic

analyses. Circulation 2001; 103: 393-400.

170. Hahn RT, Roman MJ, Mogtader AH, et al. Association of aortic dilatation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am

Coll Cardiol 1992; 19: 283-288.

171. Greenwood RD, Rosenthal A, Parisi L, et al. Extracardiac abnormalities in infants with congenital heart disease. Pediatrics 1975; 55: 485-492.

172. Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J

Med 1990; 323: 1645-1650.

173. Niwa K, Hamada H, Nakazawa M, et al. Mortality and risk factors for late deaths in tetralogy of Fallot: the Japanese Nationwide Multicenter Survey.

Cardiol Young 2002; 12: 453-460.

174. Rigatelli G and Rigatelli G. Congenital heart diseases in aged patients: Clinical features, diagnosis, and therapeutic indications based on the analysis

of a twenty five-year Medline Search. Cardiol Rev 2005; 13: 293-296.

175. Houston A, Hills S, Lilley S, et al. Echocardiography in adult congenital heart disease. Heart 1998; 80 (suppl): S12-S26.

176. 循環器病の診断と治療に関するガイドライン．循環器超音波検査の適応と判読ガイドライン．Circ J 2005; 69, Suppl．Ⅳ：1376-1385.

177. Thaulow E and Lenes K. Echocardiography in adults with congenital heart disease. Minerva Cardioangiol 2005; 53: 117-127.

178. Brickner ME, Hills LD, Lange RA. Congenital heart disease in adults. N Eng J Med 2000; 342: 256-263, 334-342.

179. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: A report of the American College of

Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of echocardiography) developed in

collaboration with the American Society of echocardiography. Circulation 1997; 95: 1686-1744 (1724−1725).

180. King ME. Echocardiographic evaluation of the adult with unoperated congenital heart disease. In Otto CM(ed): The practice of clinical

echocardiography. 2nd ed. Philadelphia, WB Sanders 2002: 868-900.

181. Stanger P, Silverman NH, Foster E. Diagnostic accuracy of pediatric echocardiograms performed in adult laboratories. Am J Cardiol 1999; 83:

908-914.

182. 循環器病の診断と治療に関するガイドライン．先天性心疾患の診断，病態把握，治療選択のための検査法の選択ガイドライン．Circ J 2009；73，Suppl．Ⅲ：

1115-1186.

183. Silverman NH, De Araujo LML. An echocardiographic method for the diagnosis of cardiac situs and malpositions. Echocardiography 1987; 4: 35-57.

184. 里見元義．心臓超音波診断アトラス─小児・胎児編─．ベクトル・コア 1991.

185. Schwerzmann M, Samman AM, Salehian O, et al. Comparison of echocardiographic and cardiac magnetic resonance imaging for assessing right

ventricular function in adults with repaired tetralogy of Fallot. Am J Cardiol 2007; 99: 1593-1597.

186. Davlouros PA, Niwa K, Webb G, et al. The right ventricle in congenital heart disease. Heart 2006; 92 (Suppl 1): i27-i38.

187. Warnes CA. Adult congenital heart disease importance of the right ventricle. J Am Coll Cardiol 2009; 54: 1903-1910.

188. Attaran RR, Ata I, Kudithipudi V, et al. Protocol for optimal detection and exclusion of a patent foramen ovale using transthoracic echocardiography

with agitated saline microbubbles. Echocardiography 2006; 23: 616-622.

189. Soliman OI, Geleijnse ML, Meijboom FJ, et al. The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr 2007; 8:

S2-12.

190. de Groot-de Laat LE, Krenning BJ, ten Cate FJ, et al. Usefulness of contrast echocardiography for diagnosis of left ventricular noncompaction. Am J

Cardiol 2005; 95: 1131-1134.

191. Sreeram N, Sutherland GR, Geuskens R, et al. The role of transesophageal echocardiography in adolescents and adults with congenital heart defects.

Eur Heart J 1991; 12: 231-240.

192. Hoppe UC, Dederichs B, Deutsch HJ, et al. Congenital heart disease in adults and adolescents: comparative value of transthoracic and

transesophageal echocardiography and MR imaging. Radiology 1996; 199: 669-677.

193. Masani ND. Transesophageal echocardiography in adult congenital heart disease. Heart 2001; 86 (suppl Ⅱ): Ⅱ 30-Ⅱ 40.

194. Miller-Hance WC, Silverman NH. Transesophageal echocardiography (TEE) in congenital heart disease with focus on the adult. Cardiol Clin 2000; 18:

861-892.

195. Ayres NA, Miller-Hance W, Fyfe DA, et al. Indication and Guidelines for performance of transesophageal echocardiography in the patient with pediatric

acquired or congenital heart disease. J Am Soc Echocardiogr 2005; 18: 91-98.

196. Marelli AJ, Child JS, Perloff JK. Transesophageal echocardiography in congenital heart disease in the adult. Cardiol Clin 1993; 11: 505-520.

197. Cooke JC, Gelman JS, Harper RW. Echocardiologists’ role in the deployment of the Amplatzer atrial septal occluder device in adults. J Am Soc

Echocardiogr 2001; 14: 588-594.

198. Mazic U, Gavora P, Masura J. The role of transesophageal echocardiography in transcatheter closure of secundum atrial septal defects by the

Amplatzer septal occluder. Am Heart J 2001; 142: 482-488.

199. Lang RM, Mor-Avi V, Sugeng L, et al. Three-dimensional echocardiography: the benefits of the additional dimension. J Am Coll Cardiol 2006; 48:

2053-2069.

200. Hung J, Lang R, Flachskampf F, et al. 3D echocardiography: a review of the current status and future directions. J Am Soc Echocardiogr 2007; 20:

213-233.

文献